Project Grant R61DA061335
Award Date
9/15/24
Completion Date
8/31/26
Dollars Obligated
$2.7M
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Kingston, RI 02881, USA
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $406,451.00 to Ksana Health Inc. to develop and refine the VIRA mobile app platform as an adjunctive treatment for opioid use disorder (OUD). The key products and services to be delivered include: Technical development and user-centered research to extend the VIRA platform's capabilities to provide just-in-time interventions for two types of cues...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop and test a prototype mobile health (mHealth) application called R-ASSIST. The $857,121 award, with a project period from Sep 30, 2024 to Sep 29, 2025, will fund a partnership between the University of Massachusetts and Meaningful Measurement, Inc., a women-owned small business, to create an app to support individuals released from jail who...
This federal Cooperative Agreement award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is intended to develop and evaluate the VIRA platform, a digital therapeutic intervention to improve outcomes for individuals with opioid use disorder (OUD) who are receiving buprenorphine treatment. The $611,665 award will fund a two-phase project to: 1) adapt and refine the VIRA platform through user-centered design and pilot testing,...
The National Institute on Drug Abuse (NIDA) awarded a Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) totaling $3,086,472 to the University of Rhode Island on September 15, 2024. The objective of this 5-year project is to evaluate the spillover effects of HIV interventions among marginalized populations, particularly young Black men who have sex with men (BMSM), who use illicit substances. The project will leverage data from three existing network studies in Chicago,...
This Project Grant award of $2,415,940.00, awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to develop digital biomarkers and phenotypes for tracking craving patterns in individuals with opioid use disorder (OUD) during medication-based treatment (MOUD). The award will fund a prospective, observational trial of 300 participants initiating MOUD with buprenorphine, methadone or naltrexone. Continuous wearable...
The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $591,752 Project Grant to Oprems LLC to develop a digital platform for electronic screening to identify the risk of opioid misuse and overdose. The project aims to integrate the tools and processes from Oprems' existing paper-based "ONE (Opioid and Naloxone Education)" program into a tablet-based digital platform. This digital platform will be used to consistently...
This federal Project Grant award of $1,948,634.00 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to adapt and test a smartphone-based mobile health (mHealth) intervention to reduce overdose risk among people who engage in polysubstance use. The study will build on previous research findings on polysubstance use patterns to develop the "OD-CHESS" intervention by adapting an existing substance use disorder...
The National Institute on Drug Abuse (NIDA) awarded a $1,076,018 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Dynamicare Health Inc. in Wareham, MA. The award will fund a Phase II randomized clinical trial to evaluate the efficacy of DCH-003, a digital therapeutic that delivers contingency management for the treatment of stimulant use disorder. The trial will compare standard clinic care plus DCH-003 to standard care plus a sham digital app, with the...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $348,756 to the University of Oklahoma Health Sciences Center to develop a mobile health (mHealth) intervention that provides psychosocial and self-management support to postpartum individuals recovering from opioid use disorder (OUD). The intervention, grounded in acceptance and commitment therapy (ACT) principles, will be iteratively developed...
This Project Grant award from the National Institute on Drug Abuse (NIDA), part of the NIH's Drug Use and Addiction Research Programs (CFDA 93.279), will fund a $751,043 research project at the University of Massachusetts Medical School focused on investigating the cellular and molecular mechanisms underlying the complex co-morbidity of opioid use disorder (OUD), major depressive disorder (MDD), and HIV in the human brain. The project will leverage single-cell sequencing technologies and other...